Clinical Trial Update: Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers [Phase 4]

View source ↗

Summary

Phase 4 trial update on behavioral activation and varenicline for smoking cessation in depressed smokers; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Northwestern University | Conditions: Nicotine Dependence, Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2021-05-27